Hari Padmanabhan

Hari Padmanabhan is an accomplished scientist with extensive experience in the field of developmental biology and hit discovery. Currently serving as the Associate Director of Hit Discovery at Life Edit Therapeutics since September 2024, Hari previously held roles at CRISPR Therapeutics from January 2017 to 2023, advancing from Scientist to Principal Scientist. Prior to this, significant research was conducted as a Postdoctoral Fellow at both Harvard University and Massachusetts General Hospital from 2008 to 2016. Hari completed a PhD in Developmental Biology at the Tata Institute of Fundamental Research from 2001 to 2008 and earned an MSc(Hons.) in Biological Sciences from the Birla Institute of Technology and Science, Pilani, from 1996 to 2001.